Greenway Medical Technologies Earnings: Everything You Must Know Now

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Greenway Medical Technologies (NYSE:GWAY) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Greenway Medical Technologies Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 87.5% to $0.01 in the quarter versus EPS of $0.08 in the year-earlier quarter.

Revenue: Rose 2.83% to $33.8 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Greenway Medical Technologies reported adjusted EPS income of $0.01 per share. By that measure, the company missed the mean analyst estimate of $0.04. It missed the average revenue estimate of $35.5 million.

Quoting Management: “Our efforts to shift the adoption of our PrimeSUITE platform from license sales to cloud-based services has accelerated the shift in our revenue streams to recurring sources during the fiscal 2013 third quarter,” said Tee Green, president and chief executive officer of Greenway®. “This has reduced our revenue from one-time systems sales and training, but moved us faster than anticipated to a business model that is recurring in nature and more predictable than we have experienced with non-recurring revenue. We’re managing through this transition in our business, continuing to add providers to our platform, growing our backlog, and increasing the percentage of our backlog and revenue that is comprised of revenue from recurring sources.”

Key Stats (on next page)…

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business